Participants were aged 40 to 80 years and had a clinical diagnosis of COPD, a smoking history of at least 10 pack-years, and evidence of chronic bronchitis. The primary endpoints included safety ...

ADMA Biologics, Inc. (Nasdaq: ADMA) ("ADMA,” the "Company,” or "we”), an end-to-end commercial biopharmaceutical company ...